These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36549027)
1. Ligand-receptor interaction in the specific targeting of biomimetic peptide nanoparticles to lysophosphatidylcholine. Wang A; Yue K; Zhong W; Zhang G; Wang L; Wang H; Zhang H; Zhang X Int J Biol Macromol; 2023 Feb; 227():193-202. PubMed ID: 36549027 [TBL] [Abstract][Full Text] [Related]
2. Delivery of rapamycin by biomimetic peptide nanoparticles targeting oxidized low-density lipoprotein in atherosclerotic plaques. Wang A; Yue K; Zhong W; Zhang G; Wang L; Zhang H; Zhang X Biomater Sci; 2024 Aug; 12(16):4181-4193. PubMed ID: 38979569 [TBL] [Abstract][Full Text] [Related]
3. Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine. Domeij H; Hua X; Su J; Bäcklund A; Yan Z; Frostegård AG; Haeggström JZ; Modéer T; Frostegård J Prostaglandins Other Lipid Mediat; 2013 Oct; 106():72-8. PubMed ID: 23391726 [TBL] [Abstract][Full Text] [Related]
4. Synthetic peptide (P-21) derived from Asp-hemolysin inhibits the induction of apoptosis on HUVECs by lysophosphatidylcholine. Tsutsumi H; Kumagai T; Naitoo S; Ebina K; Yokota K Biol Pharm Bull; 2006 May; 29(5):907-10. PubMed ID: 16651717 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine promotes intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells via an orphan G protein receptor 2-mediated signaling pathway. Zhang Q; Zhang W; Liu J; Yang H; Hu Y; Zhang M; Bai T; Chang F Bioengineered; 2021 Dec; 12(1):4520-4535. PubMed ID: 34346841 [TBL] [Abstract][Full Text] [Related]
6. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. Aoyama T; Fujiwara H; Masaki T; Sawamura T J Mol Cell Cardiol; 1999 Dec; 31(12):2101-14. PubMed ID: 10640439 [TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL. Wu R; Huang YH; Elinder LS; Frostegård J Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):626-30. PubMed ID: 9555869 [TBL] [Abstract][Full Text] [Related]
9. Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells. Naito M; Yamada K; Hayashi T; Asai K; Yoshimine N; Iguchi A Heart Vessels; 1994; 9(4):183-7. PubMed ID: 7961295 [TBL] [Abstract][Full Text] [Related]
10. Human estrogen sulfotransferase and its related fluorescently labeled decapeptides specifically interact with oxidized low-density lipoprotein. Sato A; Yamazaki M; Watanabe H; Sakurai E; Ebina K J Pept Sci; 2020 Oct; 26(10):e3274. PubMed ID: 32633098 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine promotes SREBP-2 activation via rapid cholesterol efflux and SREBP-2-independent cytokine release in human endothelial cells. Morita M; Sekine A; Urano Y; Nishimura T; Takabe W; Arai H; Hamakubo T; Kodama T; Noguchi N J Biochem; 2015 Oct; 158(4):331-8. PubMed ID: 25998247 [TBL] [Abstract][Full Text] [Related]
12. The mechanisms of lysophosphatidylcholine in the development of diseases. Liu P; Zhu W; Chen C; Yan B; Zhu L; Chen X; Peng C Life Sci; 2020 Apr; 247():117443. PubMed ID: 32084434 [TBL] [Abstract][Full Text] [Related]